KUKJEON PHARMACEUTICAL Co., Ltd

KOSDAQ:A307750 Stock Report

Market Cap: ₩269.4b

KUKJEON PHARMACEUTICAL Dividend

Dividend criteria checks 0/6

KUKJEON PHARMACEUTICAL is a dividend paying company with a current yield of 0.18%.

Key information

0.2%

Dividend yield

10%

Payout ratio

Industry average yield1.1%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share₩98.31
Dividend yield forecast in 3Yn/a

Recent dividend updates

Recent updates

KUKJEON PHARMACEUTICAL's (KOSDAQ:307750) Problems Go Beyond Poor Profit

Mar 27
KUKJEON PHARMACEUTICAL's (KOSDAQ:307750) Problems Go Beyond Poor Profit

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: A307750 is not paying a notable dividend for the KR market, therefore no need to check if payments are stable.

Growing Dividend: A307750 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

KUKJEON PHARMACEUTICAL Dividend Yield vs Market
How does A307750 dividend yield compare to the market?
SegmentDividend Yield
Company (A307750)0.2%
Market Bottom 25% (KR)1.0%
Market Top 25% (KR)3.6%
Industry Average (Pharmaceuticals)1.1%
Analyst forecast in 3 Years (A307750)n/a

Notable Dividend: A307750's dividend (0.18%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.02%).

High Dividend: A307750's dividend (0.18%) is low compared to the top 25% of dividend payers in the KR market (3.55%).


Earnings Payout to Shareholders

Earnings Coverage: A307750 is not paying a notable dividend for the KR market.


Cash Payout to Shareholders

Cash Flow Coverage: A307750 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.